HUM-ANI: the impact of climate change on infectious diseases emergence
In the context of climate change, what is the role of biodiversity as well as human activities...
19/10/2020
BNP Paribas Corporate & Investment Banking (CIB) has decided to continue its business gift policy, allocating the budget normally reserved for year-end business gifts to charities.
In 2009, CIB is committed for the second consecutive year to a global cause: the prevention and the treatment of infectious diseases. This issue is being addressed jointly with the Institut Pasteur, a non profit private foundation which contributes to the prevention and the treatment of disease, primarily infectious diseases, through research, education and public health activities at a global level, supported by the BNP Paribas Foundation.
In 2008, BNP Paribas CIB brought its financial support to the Institut Pasteur's international network of research teams and collaborative partnerships in 29 countries, involved in various issues such as hepatitis C (Spain), ameobiasis (India), typhoid fever (Ireland), dengue hemorrhagic fever (Mexico), West Nile virus (Czech republic), avian flu (France), malaria (Colombia, Brazil), measles and HIV (United Kingdom), tuberculosis (Belgium) …
A film highlights the global partnership between CIB and the Institut Pasteur, by presenting the Institut Pasteur, its missions, its worldwide presence, the history of the partnership, with a special focus on the Laboratory for Urgent Response to Biological Threats, that CIB supported in France last year.